A crucial player in immune regulation, FoxP3+ regulatory T cells (Tregs) are drawing attention for their heterogeneity and noncanonical functions. Here, we describe a Treg subpopulation that controls hematopoietic stem cell (HSC) quiescence and engraftment. These Tregs highly expressed an HSC marker, CD150, and localized within the HSC niche in the bone marrow (BM). Specific reduction of BM Tregs achieved by conditional deletion of CXCR4 in Tregs increased HSC numbers in the BM. Adenosine generated via the CD39 cell surface ectoenzyme on niche Tregs protected HSCs from oxidative stress and maintained HSC quiescence. In transplantation settings, niche Tregs prevented allogeneic (allo-) HSC rejection through adenosine and facilitated allo-HSC engraftment. Furthermore, transfer of niche Tregs promoted allo-HSC engraftment to a much greater extent than transfer of other Tregs. These results identify a unique niche-associated Treg subset and adenosine as regulators of HSC quiescence, abundance, and engraftment, further highlighting their therapeutic utility.
Pubmed ID: 29456159 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets CD40L (CD154)
View all literature mentionsThis monoclonal targets CD8α
View all literature mentionsThis monoclonal targets TCR beta chain
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets Ly-6G Ly-6C
View all literature mentionsThis monoclonal targets CD45.2
View all literature mentionsThis monoclonal targets CD45.1
View all literature mentionsThis monoclonal targets H-2Dd
View all literature mentionsThis monoclonal targets H-2Kb
View all literature mentionsThis monoclonal targets CD144
View all literature mentionsThis monoclonal targets CD31
View all literature mentionsThis monoclonal targets Ly-6A/E
View all literature mentionsThis monoclonal targets CD304
View all literature mentionsThis monoclonal targets CD150
View all literature mentionsThis monoclonal targets CD150
View all literature mentionsThis monoclonal targets CD73
View all literature mentionsThis monoclonal targets CD73
View all literature mentionsThis monoclonal targets CD73
View all literature mentionsThis monoclonal targets CD44
View all literature mentionsThis monoclonal targets CD44
View all literature mentionsThis monoclonal targets CD62L
View all literature mentionsThis monoclonal targets CD62L
View all literature mentionsThis monoclonal targets CD62L
View all literature mentionsThis monoclonal targets CD48
View all literature mentionsThis monoclonal targets CD48
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets NK-1.1
View all literature mentionsThis monoclonal targets CD357
View all literature mentionsThis monoclonal targets HELIOS
View all literature mentionsThis monoclonal targets FOXP3
View all literature mentionsThis monoclonal targets FOXP3
View all literature mentionsThis monoclonal targets CD357 (AITR/GITR)
View all literature mentionsThis monoclonal targets Ki-67
View all literature mentionsThis monoclonal targets CD152 (CTLA-4)
View all literature mentionsThis monoclonal targets CD200
View all literature mentionsThis monoclonal targets CD200
View all literature mentionsThis monoclonal targets KLRG1
View all literature mentionsThis monoclonal targets CD279 (PD-1)
View all literature mentionsThis monoclonal targets CD274 (PD-L1, B7-H1)
View all literature mentionsThis monoclonal targets CD274 (PD-L1, B7-H1)
View all literature mentionsThis monoclonal targets CD39
View all literature mentionsThis monoclonal targets CD39
View all literature mentionsThis monoclonal targets CD117 (c-Kit)
View all literature mentionsThis monoclonal targets TER-119
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD3e
View all literature mentionsThis monoclonal targets CD2
View all literature mentionsThis monoclonal targets Ly-6G/Ly-6C
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets CD45R (B220)
View all literature mentionsMus musculus with name C;129S-Adora2atm1Jfc/J from IMSR.
View all literature mentionsMus musculus with name STOCK Cxcl12tm2.1Sjm/J from IMSR.
View all literature mentionsMus musculus with name B6.129(Cg)-Leprtm2(cre)Rck/J from IMSR.
View all literature mentionsMus musculus with name STOCK Cxcl12tm1.1Sjm/J from IMSR.
View all literature mentionsMus musculus with name B6.129P2-Cxcr4tm2Yzo/J from IMSR.
View all literature mentionsMus musculus with name B6.Cg-Foxp3tm2Tch/J from IMSR.
View all literature mentionsMus musculus with name B6.129(Cg)-Foxp3tm4(YFP/icre)Ayr/J from IMSR.
View all literature mentionsMus musculus with name B6.129S1-Nt5etm1Lft/J from IMSR.
View all literature mentionsMus musculus with name B6.Cg-Tg(CAG-DsRed*MST)1Nagy/J from IMSR.
View all literature mentionsMus musculus with name C57BL/6-Tg(UBC-GFP)30Scha/J from IMSR.
View all literature mentionsMus musculus with name B10.A-H2a H2-T18/SgSnJ from IMSR.
View all literature mentionsMus musculus with name B6.SJL-Ptprca Pepc/BoyJ from IMSR.
View all literature mentionsMus musculus with name BALB/cJ from IMSR.
View all literature mentionsMus musculus with name C57BL/6J from IMSR.
View all literature mentions